APO Research
Talk to an analyst

APO RESEARCH · REPORT

Japanese Encephalitis Inactivated Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Japanese Encephalitis Inactivated Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025188 pages

Choose your research edition.

Industry ResearchJapanese Encephalitis Inactivated Vaccine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Japanese Encephalitis Inactivated Vaccine Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Japanese Encephalitis Inactivated Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Japanese Encephalitis Inactivated Vaccine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Japanese Encephalitis Inactivated Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Japanese Encephalitis Inactivated Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Japanese Encephalitis Inactivated Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Japanese Encephalitis Inactivated Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Japanese Encephalitis Inactivated Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Japanese Encephalitis Inactivated Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Japanese Encephalitis Inactivated Vaccine include Liaoning Chengda Biological Co., Ltd, Lanzhou Institute of Biological Products Co., Ltd, Chengdu Institute of Biological Products Co., Ltd, Beijing Institute of Biological Products Co., Ltd, Valneva, Sanofi Pasteur and Biken, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Japanese Encephalitis Inactivated Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Japanese Encephalitis Inactivated Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Japanese Encephalitis Inactivated Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Japanese Encephalitis Inactivated Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Japanese Encephalitis Inactivated Vaccine Segment by Company

Liaoning Chengda Biological Co., Ltd

Lanzhou Institute of Biological Products Co., Ltd

Chengdu Institute of Biological Products Co., Ltd

Beijing Institute of Biological Products Co., Ltd

Valneva

Sanofi Pasteur

Biken

Japanese Encephalitis Inactivated Vaccine Segment by Type

Adult

Child

Japanese Encephalitis Inactivated Vaccine Segment by Application

Hospital

Clinic

Japanese Encephalitis Inactivated Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Japanese Encephalitis Inactivated Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Japanese Encephalitis Inactivated Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Japanese Encephalitis Inactivated Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Japanese Encephalitis Inactivated Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Japanese Encephalitis Inactivated Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Japanese Encephalitis Inactivated Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Japanese Encephalitis Inactivated Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Japanese Encephalitis Inactivated Vaccine Industry Trends Table 2. Japanese Encephalitis Inactivated Vaccine Industry Drivers Table 3. Japanese Encephalitis Inactivated Vaccine Industry Opportunities and Challenges Table 4. Japanese Encephalitis Inactivated Vaccine Industry Restraints Table 5. Global Japanese Encephalitis Inactivated Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Japanese Encephalitis Inactivated Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Manufacturers Table 9. Global Japanese Encephalitis Inactivated Vaccine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Japanese Encephalitis Inactivated Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Japanese Encephalitis Inactivated Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Japanese Encephalitis Inactivated Vaccine Manufacturers, Product Type & Application Table 13. Global Japanese Encephalitis Inactivated Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Japanese Encephalitis Inactivated Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Adult Table 17. Major Manufacturers of Child Table 18. Global Japanese Encephalitis Inactivated Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Global Japanese Encephalitis Inactivated Vaccine Sales by Type (2027-2032) & (K Units) Table 21. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Japanese Encephalitis Inactivated Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Japanese Encephalitis Inactivated Vaccine Revenue by Type (2021-2026) & (K Units) Table 25. Global Japanese Encephalitis Inactivated Vaccine Revenue by Type (2027-2032) & (K Units) Table 26. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Global Japanese Encephalitis Inactivated Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2026) & (K Units) Table 32. Global Japanese Encephalitis Inactivated Vaccine Sales by Application (2027-2032) & (K Units) Table 33. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Japanese Encephalitis Inactivated Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Japanese Encephalitis Inactivated Vaccine Revenue by Application (2021-2026) & (K Units) Table 37. Global Japanese Encephalitis Inactivated Vaccine Revenue by Application (2027-2032) & (K Units) Table 38. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Japanese Encephalitis Inactivated Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Japanese Encephalitis Inactivated Vaccine Sales by Region (2021-2026) & (K Units) Table 42. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Japanese Encephalitis Inactivated Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Japanese Encephalitis Inactivated Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Japanese Encephalitis Inactivated Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2026) & (K Units) Table 47. North America Japanese Encephalitis Inactivated Vaccine Sales by Country (2027-2032) & (K Units) Table 48. Europe Japanese Encephalitis Inactivated Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2026) & (K Units) Table 50. Europe Japanese Encephalitis Inactivated Vaccine Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Japanese Encephalitis Inactivated Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Japanese Encephalitis Inactivated Vaccine Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales by Country (2027-2032) & (K Units) Table 57. Global Japanese Encephalitis Inactivated Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Japanese Encephalitis Inactivated Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Japanese Encephalitis Inactivated Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Region (2027-2032) Table 62. Liaoning Chengda Biological Co., Ltd Company Information Table 63. Liaoning Chengda Biological Co., Ltd Business Overview Table 64. Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 66. Liaoning Chengda Biological Co., Ltd Recent Development Table 67. Lanzhou Institute of Biological Products Co., Ltd Company Information Table 68. Lanzhou Institute of Biological Products Co., Ltd Business Overview Table 69. Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 71. Lanzhou Institute of Biological Products Co., Ltd Recent Development Table 72. Chengdu Institute of Biological Products Co., Ltd Company Information Table 73. Chengdu Institute of Biological Products Co., Ltd Business Overview Table 74. Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 76. Chengdu Institute of Biological Products Co., Ltd Recent Development Table 77. Beijing Institute of Biological Products Co., Ltd Company Information Table 78. Beijing Institute of Biological Products Co., Ltd Business Overview Table 79. Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 81. Beijing Institute of Biological Products Co., Ltd Recent Development Table 82. Valneva Company Information Table 83. Valneva Business Overview Table 84. Valneva Japanese Encephalitis Inactivated Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Valneva Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 86. Valneva Recent Development Table 87. Sanofi Pasteur Company Information Table 88. Sanofi Pasteur Business Overview Table 89. Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 91. Sanofi Pasteur Recent Development Table 92. Biken Company Information Table 93. Biken Business Overview Table 94. Biken Japanese Encephalitis Inactivated Vaccine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Biken Japanese Encephalitis Inactivated Vaccine Product Portfolio Table 96. Biken Recent Development Table 97. Key Raw Materials Table 98. Raw Materials Key Suppliers Table 99. Japanese Encephalitis Inactivated Vaccine Distributors List Table 100. Japanese Encephalitis Inactivated Vaccine Customers List Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Japanese Encephalitis Inactivated Vaccine Product Image Figure 2. Global Japanese Encephalitis Inactivated Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Japanese Encephalitis Inactivated Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Japanese Encephalitis Inactivated Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Japanese Encephalitis Inactivated Vaccine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Japanese Encephalitis Inactivated Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Adult Image Figure 9. Child Image Figure 10. Global Japanese Encephalitis Inactivated Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Japanese Encephalitis Inactivated Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Global Japanese Encephalitis Inactivated Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Japanese Encephalitis Inactivated Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Japanese Encephalitis Inactivated Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Japanese Encephalitis Inactivated Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Japanese Encephalitis Inactivated Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Japanese Encephalitis Inactivated Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Japanese Encephalitis Inactivated Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Japanese Encephalitis Inactivated Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Japanese Encephalitis Inactivated Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Japanese Encephalitis Inactivated Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Adult
  • Child
Applications
  • Hospital
  • Clinic
Companies covered
  • Liaoning Chengda Biological Co., Ltd
  • Lanzhou Institute of Biological Products Co., Ltd
  • Chengdu Institute of Biological Products Co., Ltd
  • Beijing Institute of Biological Products Co., Ltd
  • Valneva
  • Sanofi Pasteur
  • Biken

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Japanese Encephalitis Inactivated Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Japanese Encephalitis Inactivated Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Japanese Encephalitis Inactivated Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Japanese Encephalitis Inactivated Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Japanese Encephalitis Inactivated Vaccine Market Dynamics
  1. 2.1 Japanese Encephalitis Inactivated Vaccine Industry Trends
  2. 2.2 Japanese Encephalitis Inactivated Vaccine Industry Drivers
  3. 2.3 Japanese Encephalitis Inactivated Vaccine Industry Opportunities and Challenges
  4. 2.4 Japanese Encephalitis Inactivated Vaccine Industry Restraints
3 Japanese Encephalitis Inactivated Vaccine Market by Manufacturers
  1. 3.1 Global Japanese Encephalitis Inactivated Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Japanese Encephalitis Inactivated Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Japanese Encephalitis Inactivated Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Japanese Encephalitis Inactivated Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Japanese Encephalitis Inactivated Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Japanese Encephalitis Inactivated Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Japanese Encephalitis Inactivated Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Japanese Encephalitis Inactivated Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Japanese Encephalitis Inactivated Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Japanese Encephalitis Inactivated Vaccine Tier 1, Tier 2, and Tier 3
4 Japanese Encephalitis Inactivated Vaccine Market by Type
  1. 4.1 Japanese Encephalitis Inactivated Vaccine Type Introduction
  2. 4.1.1 Adult
  3. 4.1.2 Child
  4. 4.2 Global Japanese Encephalitis Inactivated Vaccine Sales by Type
  5. 4.2.1 Global Japanese Encephalitis Inactivated Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Japanese Encephalitis Inactivated Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Japanese Encephalitis Inactivated Vaccine Revenue by Type
  9. 4.3.1 Global Japanese Encephalitis Inactivated Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Japanese Encephalitis Inactivated Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Type (2021-2032)
5 Japanese Encephalitis Inactivated Vaccine Market by Application
  1. 5.1 Japanese Encephalitis Inactivated Vaccine Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Japanese Encephalitis Inactivated Vaccine Sales by Application
  5. 5.2.1 Global Japanese Encephalitis Inactivated Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Japanese Encephalitis Inactivated Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Japanese Encephalitis Inactivated Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Japanese Encephalitis Inactivated Vaccine Revenue by Application
  9. 5.3.1 Global Japanese Encephalitis Inactivated Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Japanese Encephalitis Inactivated Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Application (2021-2032)
6 Global Japanese Encephalitis Inactivated Vaccine Sales by Region
  1. 6.1 Global Japanese Encephalitis Inactivated Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Japanese Encephalitis Inactivated Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Japanese Encephalitis Inactivated Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Japanese Encephalitis Inactivated Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Japanese Encephalitis Inactivated Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Japanese Encephalitis Inactivated Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Japanese Encephalitis Inactivated Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Japanese Encephalitis Inactivated Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Japanese Encephalitis Inactivated Vaccine Revenue by Region
  1. 7.1 Global Japanese Encephalitis Inactivated Vaccine Revenue by Region
  2. 7.1.1 Global Japanese Encephalitis Inactivated Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Japanese Encephalitis Inactivated Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Japanese Encephalitis Inactivated Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Japanese Encephalitis Inactivated Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Japanese Encephalitis Inactivated Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Japanese Encephalitis Inactivated Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Japanese Encephalitis Inactivated Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Japanese Encephalitis Inactivated Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Japanese Encephalitis Inactivated Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Liaoning Chengda Biological Co., Ltd
  2. 8.1.1 Liaoning Chengda Biological Co., Ltd Company Information
  3. 8.1.2 Liaoning Chengda Biological Co., Ltd Business Overview
  4. 8.1.3 Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Liaoning Chengda Biological Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio
  6. 8.1.5 Liaoning Chengda Biological Co., Ltd Recent Developments
  7. 8.2 Lanzhou Institute of Biological Products Co., Ltd
  8. 8.2.1 Lanzhou Institute of Biological Products Co., Ltd Company Information
  9. 8.2.2 Lanzhou Institute of Biological Products Co., Ltd Business Overview
  10. 8.2.3 Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Lanzhou Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio
  12. 8.2.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments
  13. 8.3 Chengdu Institute of Biological Products Co., Ltd
  14. 8.3.1 Chengdu Institute of Biological Products Co., Ltd Company Information
  15. 8.3.2 Chengdu Institute of Biological Products Co., Ltd Business Overview
  16. 8.3.3 Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Chengdu Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio
  18. 8.3.5 Chengdu Institute of Biological Products Co., Ltd Recent Developments
  19. 8.4 Beijing Institute of Biological Products Co., Ltd
  20. 8.4.1 Beijing Institute of Biological Products Co., Ltd Company Information
  21. 8.4.2 Beijing Institute of Biological Products Co., Ltd Business Overview
  22. 8.4.3 Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Beijing Institute of Biological Products Co., Ltd Japanese Encephalitis Inactivated Vaccine Product Portfolio
  24. 8.4.5 Beijing Institute of Biological Products Co., Ltd Recent Developments
  25. 8.5 Valneva
  26. 8.5.1 Valneva Company Information
  27. 8.5.2 Valneva Business Overview
  28. 8.5.3 Valneva Japanese Encephalitis Inactivated Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Valneva Japanese Encephalitis Inactivated Vaccine Product Portfolio
  30. 8.5.5 Valneva Recent Developments
  31. 8.6 Sanofi Pasteur
  32. 8.6.1 Sanofi Pasteur Company Information
  33. 8.6.2 Sanofi Pasteur Business Overview
  34. 8.6.3 Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sanofi Pasteur Japanese Encephalitis Inactivated Vaccine Product Portfolio
  36. 8.6.5 Sanofi Pasteur Recent Developments
  37. 8.7 Biken
  38. 8.7.1 Biken Company Information
  39. 8.7.2 Biken Business Overview
  40. 8.7.3 Biken Japanese Encephalitis Inactivated Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Biken Japanese Encephalitis Inactivated Vaccine Product Portfolio
  42. 8.7.5 Biken Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Japanese Encephalitis Inactivated Vaccine Value Chain Analysis
  2. 9.1.1 Japanese Encephalitis Inactivated Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Japanese Encephalitis Inactivated Vaccine Production Mode & Process
  6. 9.2 Japanese Encephalitis Inactivated Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Japanese Encephalitis Inactivated Vaccine Distributors
  9. 9.2.3 Japanese Encephalitis Inactivated Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst